1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
2. Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA;
3. Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
4. Department of Biostatistics, University of Washington School of Public Health, Seattle, WA;
5. Massachusetts General Hospital, Harvard Medical School, Boston, MA;
6. Leukemia & Myeloid Disorders Program, Cleveland Clinic, Cleveland, OH;
7. Division of Hematology, Department of Medicine, Stanford University, Stanford, CA;
8. Roswell Park Cancer Institute, Buffalo, NY;
9. Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;
10. Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada;
11. Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL;
12. Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;
13. Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD;
14. Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC;
15. Division of Oncology, Washington University School of Medicine, St Louis, MO;
16. John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ;
17. Confluence Health/Wenatchee Valley Hospital and Clinic, Wenatchee, WA;
18. Skagit Valley Hospital, Mount Vernon, WA;
19. Penn State College of Medicine, Hershey, PA;
20. Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and
21. Department of Population Sciences, City of Hope, Duarte, CA